Ekso Bionics (EKSO) Competitors $0.72 +0.01 (+1.41%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends EKSO vs. PDYN, RR, TRSG, FTEK, ZOOZ, TRT, SHMD, CVV, LIQT, and ARTWShould you be buying Ekso Bionics stock or one of its competitors? The main competitors of Ekso Bionics include Palladyne AI (PDYN), Richtech Robotics (RR), Tungray Technologies (TRSG), Fuel Tech (FTEK), ZOOZ Power (ZOOZ), Trio-Tech International (TRT), SCHMID Group (SHMD), CVD Equipment (CVV), LiqTech International (LIQT), and Art's-Way Manufacturing (ARTW). These companies are all part of the "machinery" industry. Ekso Bionics vs. Palladyne AI Richtech Robotics Tungray Technologies Fuel Tech ZOOZ Power Trio-Tech International SCHMID Group CVD Equipment LiqTech International Art's-Way Manufacturing Ekso Bionics (NASDAQ:EKSO) and Palladyne AI (NASDAQ:PDYN) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, community ranking, earnings, analyst recommendations, valuation, risk, media sentiment and dividends. Does the media refer more to EKSO or PDYN? In the previous week, Ekso Bionics had 3 more articles in the media than Palladyne AI. MarketBeat recorded 5 mentions for Ekso Bionics and 2 mentions for Palladyne AI. Palladyne AI's average media sentiment score of 0.62 beat Ekso Bionics' score of 0.26 indicating that Palladyne AI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ekso Bionics 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Palladyne AI 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend EKSO or PDYN? Ekso Bionics presently has a consensus target price of $5.50, indicating a potential upside of 664.95%. Given Ekso Bionics' stronger consensus rating and higher possible upside, research analysts plainly believe Ekso Bionics is more favorable than Palladyne AI.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ekso Bionics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Palladyne AI 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk and volatility, EKSO or PDYN? Ekso Bionics has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500. Comparatively, Palladyne AI has a beta of 3.3, suggesting that its share price is 230% more volatile than the S&P 500. Is EKSO or PDYN more profitable? Ekso Bionics has a net margin of -62.95% compared to Palladyne AI's net margin of -722.22%. Palladyne AI's return on equity of -56.81% beat Ekso Bionics' return on equity.Company Net Margins Return on Equity Return on Assets Ekso Bionics-62.95% -83.09% -39.03% Palladyne AI -722.22%-56.81%-37.45% Which has higher valuation and earnings, EKSO or PDYN? Ekso Bionics has higher revenue and earnings than Palladyne AI. Ekso Bionics is trading at a lower price-to-earnings ratio than Palladyne AI, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEkso Bionics$18.28M0.87-$15.20M-$0.65-1.11Palladyne AI$6.15M8.45-$115.59M-$2.16-0.90 Do insiders & institutionals have more ownership in EKSO or PDYN? 6.4% of Ekso Bionics shares are held by institutional investors. Comparatively, 26.0% of Palladyne AI shares are held by institutional investors. 6.1% of Ekso Bionics shares are held by insiders. Comparatively, 12.0% of Palladyne AI shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community believe in EKSO or PDYN? Ekso Bionics received 322 more outperform votes than Palladyne AI when rated by MarketBeat users. CompanyUnderperformOutperformEkso BionicsOutperform Votes32255.71% Underperform Votes25644.29% Palladyne AIN/AN/A SummaryEkso Bionics beats Palladyne AI on 9 of the 17 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get Ekso Bionics News Delivered to You Automatically Sign up to receive the latest news and ratings for EKSO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EKSO vs. The Competition Export to ExcelMetricEkso BionicsGeneral industrial machinery, IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.55M$4.30B$5.05B$8.87BDividend YieldN/A0.77%4.97%4.06%P/E Ratio-1.1113.2797.3414.18Price / Sales0.875.041,218.4289.42Price / CashN/A15.7333.5132.79Price / Book1.063.005.805.12Net Income-$15.20M$10.45M$119.07M$225.99M7 Day Performance-5.27%1.66%-1.83%-1.32%1 Month Performance-30.19%-2.36%-3.64%0.60%1 Year Performance-51.42%4.11%31.62%26.23% Ekso Bionics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EKSOEkso Bionics3.0287 of 5 stars$0.72+1.4%$5.50+665.0%-50.8%$15.55M$18.28M-1.1160Analyst ForecastGap UpPDYNPalladyne AI1.4329 of 5 stars$1.94+7.8%N/AN/A$48.24M$6.15M0.0070Gap UpHigh Trading VolumeRRRichtech Robotics0.0972 of 5 stars$0.53-7.0%N/A-90.6%$45.18M$8.76M0.0051TRSGTungray TechnologiesN/A$2.31+1.3%N/AN/A$37.05M$14.36M0.00N/AGap DownFTEKFuel Tech3.2033 of 5 stars$1.05-1.9%$4.00+281.0%+0.0%$32.86M$27.08M0.0070Analyst ForecastHigh Trading VolumeZOOZZOOZ Power3.1671 of 5 stars$2.77+3.0%$5.00+80.5%N/A$32.53M$760,000.000.0050Positive NewsGap DownTRTTrio-Tech InternationalN/A$6.88+3.3%N/A+31.8%$28.31M$42.31M47.57740Analyst ForecastNews CoverageGap UpSHMDSCHMID GroupN/A$2.39-4.8%N/AN/A$25.41MN/A0.00800CVVCVD Equipment1.5255 of 5 stars$3.11+1.6%N/A-35.9%$21.06M$23.57M-4.94110Analyst ForecastLIQTLiqTech International2.5453 of 5 stars$1.63-5.8%$5.58+242.0%-54.3%$10.11M$18M0.00120Analyst ForecastHigh Trading VolumeARTWArt's-Way Manufacturing0.348 of 5 stars$1.65+0.6%N/A-19.1%$8.30M$30.28M0.00100Analyst Forecast Related Companies and Tools Related Companies PDYN Alternatives RR Alternatives TRSG Alternatives FTEK Alternatives ZOOZ Alternatives TRT Alternatives SHMD Alternatives CVV Alternatives LIQT Alternatives ARTW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:EKSO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ekso Bionics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ekso Bionics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
